Alliance for Human Research Protection / DSaRM Open Public Hearing Statement office of Drug Safety Updates Gerald Dal Pan / office of Drug Safety Overview of Attention Deficit Hyperactivity Disorder / Food and Drug Administration / Drug Safety Oversight Board / American Academy of Dermatology Associations / Risk Management Advisory Committee / office of Drug Safety New Drug / International Center for the Study of Psychiatry and Psychology / The Committee / Drug Safety and Risk Management Advisory Committee / American Psychiatric Association / Commission on Human Rights / Center for Drug Evaluation and Research / Healthcare Distribution Management Association / American Academy of Child and Adolescent Psychiatry / office of Drug Safety / /
Person
Stephanie Crawford / Sean Hennessy / Ellen Bleecker Liversidge / Eleanor Gomez-Fein / Terry Davis / Annette Stemhagen / Susan Ackermann Shiff / Lawrence Greenhill / Louis Morris / Solomon Iyasu / Elizabeth Andrews / Richard Platt / James Shamp / Tim Cochran / Curt Furberg / John Moore / Agostino / Thomas Fleming / Peter Gross / Review Sharon Hertz / Eric Holmboe / Henri Manasse / Steven Nissen / Todd Gruber / Sharon Hertz / Robyn Shapiro / Albert Allen / Christine Mundkur / Susan Cummins / Sandra Lucas / Deborah Dokken / David Graham / Gerald DalPan / Andrew Mosholder / M. Christopher Griffith / Arthur Levin / Diane Thiboutot / Kate Gelperin / Jill Lindstrom / Michael Cohen / Allen Jones / Marsha Rappley / Tom Laughren / Jacqueline Gardner / Victoria Ferretti-Aceto / /
Position
Speaker / PhD Global Head / Risk Management / Director / Executive Secretary / VP / Quality and Regulatory Counsel / Chair / Representative / /
These summary minutes for the February 9 and 10, 2006, meeting of the Drug Safety and Risk Management Advisory Committee were approved on ___2/22/06____.